ENKORE

Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments

Summary

The healthcare sector has a significant impact on the environment, in terms of both resource use and waste generation. Medical devices, particularly single-use devices, and their packaging generate substantial amounts of waste, including plastics and hazardous materials that are challenging to manage. Applying ‘circular economy’ principles to the sector could reduce these impacts, but doing this is far from easy. Because medical devices are often used on or in the body, and must be sterile, there are very strict rules governing the kinds of materials that can be used to make them and their packaging. This makes it hard to use environmentally friendly materials, such as recycled materials, for example.

To address these environmental concerns, ENKORE seeks to develop an eco-design framework for single-use medical devices and their packaging. The project brings together experts from the healthcare, materials technology, and packaging sectors, along with healthcare providers and pharmaceutical and medical technology companies. By integrating sustainable practices into the design and manufacturing processes, the project aims to reduce the ecological footprint of medical devices, paving the way for a more environmentally responsible healthcare sector.

The ENKORE project will design and co-create a catalogue of key enabling materials (KEM) and key end-of-cycle sustainable solutions (KES). These will form the core of the eco-design framework. For the materials, the project will focus on innovative materials that would minimise waste, optimise resource usage and reduce the carbon footprint, while ensuring devices are safe for patients and have the mechanical and physical properties required of them to do their job. For end-of-cycle solutions, the project will collect sustainable solutions for both healthcare providers and people using devices in their own homes, for example.

The KES and KEM are intrinsically connected, as end-of-cycle factors significantly influence the selection of materials, while the end-of-cycle solutions must account for the materials used.

The project will also develop strategies to promote more effective waste management and circularity of medical devices at healthcare providers and in patients’ homes.

The project plans to test the eco-design framework through use cases in five regional healthcare systems across Europe. The use cases will cover a wide range of devices, packaging, and waste types, including drug injection devices; single-use products in dialysis; plastic and cellulose materials for packaging; and the management of waste (including contaminated waste) in hospitals.

Ultimately, ENKORE hopes its eco-design framework will accelerate innovation and support the delivery of products that are both safe for patients and environmentally responsible.

Participants

  Show participants on map
Universities, research organisations, public bodies, non-profit groups
  • Agenzia Regionale Per La Salute Ed Il Sociale, Bari, Italy
  • Charite - Universitaetsmedizin Berlin, Berlin, Germany
  • Consorcio Mar Parc De Salut De Barcelona, Barcelona, Spain
  • Enosi Asthenon Elladas, Athina, Greece
  • European Regional And Local Health Authorities Asbl, Etterbeek, Belgium
  • Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
  • Fundacion Universidad Francisco De Vitoria, Pozuelo De Alarcon, Spain
  • Idryma Technologias Kai Erevnas, Irakleio, Greece
  • International Solid Waste Association, Rotterdam, Netherlands
  • Naucnoistrazivacki Institut Verlab Za Biomedicinski Inzinjering Medicinske Uredaje I Vjestacku Inteligenciju, Sarajevo, Bosnia and Herzegovina
  • Politechnika Poznanska, Poznan, Poland
  • Samenwerkende Topklinische Opleidingsziekenhuizen, Utrecht, Netherlands
  • Servicio Madrileno De Salud, Madrid, Spain
  • Tech Hive Labs Astiki Mi Kerdoskopiki Etaireia, Chalandri, Greece
  • Udg Alliance, Lausanne, Switzerland
  • Universidad Politecnica De Madrid, Madrid, Spain
  • Universita Campus Bio Medico Di Roma, Roma, Italy
  • Universiteit Leiden, Leiden, Netherlands
  • Universytet Medyczny W Lodzi., Lodz, Poland
  • World Resources Forum Association, St.Gallen, Switzerland
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
  • Active Ageing Association, Paterna, Spain
  • Happy Mondays Communication SL, Pozuelo De Alarcon, Spain
  • Institoyto Bioiatrikis Texnologias, Patras, Greece
  • Multimed Engineers SRL, Parma, Italy
  • Osai Automation System S.A Societa' Benefit, Torino, Italy
  • Predictby Research And Consulting S.L., Barcelona, Spain
  • Sterimed Holding, Boulogne Billancourt, France
  • Technovative Solutions LTD, Manchester, United Kingdom
Patient organisations
  • Forum Des Patients Europeens, Brussels / Bruxelles, Belgium
Third parties
  • Sofradim Production Sasu, Trevoux, France
IHI industry partners
  • Baxter R And D Europe, Lessines, Belgium
  • Boehringer Ingelheim Internationalgmbh, Ingelheim, Germany
  • Boehringer Ingelheim Pharma GMBH &Co Kg, Ingelheim, Germany
  • Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, United States
  • DePuy International Limited, Leeds, United Kingdom
  • Dupont De Nemours (Luxembourg) SARL, Luxembourg, Luxembourg
  • Eli Lilly And Company, Indianapolis, United States
  • Eli Lilly And Company LTD, Basingstoke, United Kingdom
  • Eli Lilly Danmark A/S, Herlev, Denmark
  • Fresenius Medical Care Deutschland GMBH, Bad Homburg, Germany
  • Johnson & Johnson Medical GMBH, Norderstedt, Germany
  • Johnson & Johnson Services, Inc., New Brunswick, United States
  • Lilly Deutschland GmbH, Bad Homburg, Germany
  • Medtronic Iberica SA, Madrid, Spain
  • Novo Nordisk A/S, Bagsvaerd, Denmark
  • Pfizer Inc, New York City, United States
  • Pfizer Ireland Pharmaceuticals, Cork, Ireland
  • Pfizer Italia s.r.l., Latina, Italy
  • Pfizer Limited, Sandwich, United Kingdom
  • Pfizer Manufacturing Deutschland GmbH mit Sitz Illertissen, Illertissen, Germany
  • Pfizer R&D UK Limited, Sandwich, United Kingdom
  • Takeda Pharmaceuticals International AG, Glattpark, Switzerland

Participants
NameEU funding in €
Active Ageing Association185 000
Agenzia Regionale Per La Salute Ed Il Sociale250 000
Charite - Universitaetsmedizin Berlin349 000
Consorcio Mar Parc De Salut De Barcelona250 000
Enosi Asthenon Elladas205 000
European Regional And Local Health Authorities Asbl253 750
Fondazione Policlinico Universitario Campus Bio Medico335 700
Forum Des Patients Europeens88 750
Fundacion Universidad Francisco De Vitoria229 250
Happy Mondays Communication SL432 500
Idryma Technologias Kai Erevnas206 875
Institoyto Bioiatrikis Texnologias221 500
International Solid Waste Association150 000
Multimed Engineers SRL203 125
Naucnoistrazivacki Institut Verlab Za Biomedicinski Inzinjering Medicinske Uredaje I Vjestacku Inteligenciju192 813
Osai Automation System S.A Societa' Benefit293 750
Politechnika Poznanska290 238
Predictby Research And Consulting S.L.498 750
Samenwerkende Topklinische Opleidingsziekenhuizen393 750
Servicio Madrileno De Salud211 875
Sterimed Holding481 250
Tech Hive Labs Astiki Mi Kerdoskopiki Etaireia347 500
Universidad Politecnica De Madrid578 125
Universita Campus Bio Medico Di Roma391 250
Universiteit Leiden469 000
Universytet Medyczny W Lodzi.233 750
Total Cost7 742 501